 <h1>Orfadin Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>nitisinone</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about nitisinone. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Orfadin.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to nitisinone: oral capsule, oral suspension, oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, nitisinone (the active ingredient contained in Orfadin) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking nitisinone:</p><p>
<i>Less common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>bleeding gums</li>
<li>blindness</li>
<li>blood in the urine or stools</li>
<li>bloody nose</li>
<li>blurred vision</li>
<li>burning, dry, or itching eyes</li>
<li>change in color vision</li>
<li>chest pain or discomfort</li>
<li>chills</li>
<li>cough</li>
<li>decreased vision</li>
<li>difficulty seeing at night</li>
<li>excessive eye tearing</li>
<li>eye redness, irritation, or pain</li>
<li>fever</li>
<li>increased sensitivity of the eyes to sunlight</li>
<li>painful or difficult urination</li>
<li>pinpoint red spots on the skin</li>
<li>redness, pain, swelling of the eye, eyelid, or inner lining of the eyelid</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>swollen or painful glands</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Agitation</li>
<li>back pain</li>
<li>bluish color of the fingernails, lips, skin, palms, or nail beds</li>
<li>confusion</li>
<li>cough with mucus</li>
<li>difficulty with breathing</li>
<li>dizziness</li>
<li>drowsiness</li>
<li>fast heartbeat</li>
<li>headache</li>
<li>irritability</li>
<li>seeing or hearing things that are not there</li>
<li>seizures</li>
<li>stiff neck</li>
<li>tightness in the chest</li>
<li>vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of nitisinone may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Dry skin</li>
<li>hair loss or thinning</li>
<li>itching or skin rash</li>
<li>red, swollen skin</li>
<li>scaly skin</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Cold sweats</li>
<li>cool, pale skin</li>
<li>depression</li>
<li>headache</li>
<li>increased hunger</li>
<li>nausea</li>
<li>nightmares</li>
<li>shakiness</li>
<li>slurred speech</li>
<li>stomach pain</li>
</ul><p>
<!-- end oral capsule, oral suspension, oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to nitisinone: oral capsule, oral suspension, oral tablet</i></p><h3>General</h3><p>The more commonly reported side effects have included elevated tyrosine levels, thrombocytopenia, leukopenia, conjunctivitis, corneal opacity, keratitis, photophobia, eye pain, blepharitis, cataracts, granulocytopenia, epistaxis, pruritus, exfoliative dermatitis, dry skin, maculopapular rash, and alopecia.<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Liver failure (7%), porphyria (1%)</p>
<p><b>Frequency not reported</b>: Hepatic function disorder, elevated hepatic enzymes, liver enlargement<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Thrombocytopenia (3%), leucopenia (3%), granulocytopenia (1%), epistaxis (1%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Anemia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Elevated tyrosine levels (10% or greater) </p>
<p><b>Uncommon</b> (0.1% to 1%): Dehydration, hypoglycemia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Seizures, brain tumor, encephalopathy, headache, hyperkinesia, nervousness, somnolence<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Conjunctivitis (2%), corneal opacity (2%), keratitis (2%), photophobia (2%), blepharitis (1%), eye pain (1%), cataracts (1%)<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Hepatic neoplasm (hepatic neoplasm [3.2%]; hepatic neoplasm, malignant [4.4%])</p>
<p><b>Uncommon</b> (0.1% to 1%): Benign brain neoplasm; lymphoma, malignant<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Pruritus (1%), exfoliative dermatitis (1%), dry skin (1%), maculopapular rash (1%), alopecia (1%)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Frequency not reported</b>: Abdominal pain, diarrhea, enanthema, gastritis, gastroenteritis, gastrointestinal hemorrhage, melena, tooth discoloration<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Amenorrhea, hematuria<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Pathological fracture<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Death, cyanosis, thirst, infection, septicemia, otitis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Bronchitis, respiratory insufficiency, cyanosis<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Orfadin (nitisinone)." Orphan Pharmaceuticals USA, Inc, Nashville, TN. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Orfadin (nitisinone)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Generic Availability</li>
<li>Drug class: miscellaneous metabolic agents</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Orfadin &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Nityr</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Hereditary Tyrosinemia Type 1</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to nitisinone: oral capsule, oral suspension, oral tablet</i></p><h3>General</h3><p>The more commonly reported side effects have included elevated tyrosine levels, thrombocytopenia, leukopenia, conjunctivitis, corneal opacity, keratitis, photophobia, eye pain, blepharitis, cataracts, granulocytopenia, epistaxis, pruritus, exfoliative dermatitis, dry skin, maculopapular rash, and alopecia.<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Liver failure (7%), porphyria (1%)</p><p><b>Frequency not reported</b>: Hepatic function disorder, elevated hepatic enzymes, liver enlargement<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Thrombocytopenia (3%), leucopenia (3%), granulocytopenia (1%), epistaxis (1%)</p><p><b>Uncommon</b> (0.1% to 1%): Anemia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Elevated tyrosine levels (10% or greater) </p><p><b>Uncommon</b> (0.1% to 1%): Dehydration, hypoglycemia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Seizures, brain tumor, encephalopathy, headache, hyperkinesia, nervousness, somnolence<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Conjunctivitis (2%), corneal opacity (2%), keratitis (2%), photophobia (2%), blepharitis (1%), eye pain (1%), cataracts (1%)<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Hepatic neoplasm (hepatic neoplasm [3.2%]; hepatic neoplasm, malignant [4.4%])</p><p><b>Uncommon</b> (0.1% to 1%): Benign brain neoplasm; lymphoma, malignant<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Pruritus (1%), exfoliative dermatitis (1%), dry skin (1%), maculopapular rash (1%), alopecia (1%)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Frequency not reported</b>: Abdominal pain, diarrhea, enanthema, gastritis, gastroenteritis, gastrointestinal hemorrhage, melena, tooth discoloration<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Amenorrhea, hematuria<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Pathological fracture<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Death, cyanosis, thirst, infection, septicemia, otitis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Bronchitis, respiratory insufficiency, cyanosis<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Orfadin (nitisinone)." Orphan Pharmaceuticals USA, Inc, Nashville, TN. </p><h2>More about Orfadin (nitisinone)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Generic Availability</li>
<li>Drug class: miscellaneous metabolic agents</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Orfadin &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Hereditary Tyrosinemia Type 1</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>